# FST-100 in the Treatment of Acute Adenoviral Conjunctivitis

> **NCT01470664** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 176 (actual)

## Conditions studied

- Acute Adenoviral Conjunctivitis

## Interventions

- **DRUG:** FST-100
- **DRUG:** FST-100 (Component #1)
- **DRUG:** FST-100 Vehicle

## Key facts

- **NCT ID:** NCT01470664
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-17
- **Primary completion:** 2014-05-23
- **Final completion:** 2014-05-23
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470664, "FST-100 in the Treatment of Acute Adenoviral Conjunctivitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01470664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*